| |
|
|
|
Fennec Pharmaceuticals Inc.  
|
|
0 (0%) |
|
|
Open: |
|
Pre close: |
|
Target:
|
8.59
|
|
High: |
|
Low: |
|
Resistance:
|
7.35
8.23
|
|
Volume: |
|
Market Cap: |
0M |
Support:
|
5.94
4.94
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.60
 |
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
6.91 |
Signal(12,26,9): |
-0.22 |
|
MA(100): |
8.24 |
Stochastic Oscillator |
%K(14,3):
|
31.64 |
|
MA(250): |
9.60 |
%D(3): |
41.26 |
|
Average Volume(K) |
3-Month: |
7551
|
52-Week |
High:
|
14.99 |
|
10-Days: |
3659 |
Low: |
5.94 |
|
RSI |
RSI(14):
|
36.28 |
Change(%): |
-33.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.520 |
Return on Equity (ttm) |
-58.1 |
Shares Out. (M) |
19.10 |
|
EPS Est. Current Year |
-0.230 |
Return on Assets (ttm) |
-53.0 |
Shares Float (M) |
19.10 |
|
EPS Est. Next Year |
-0.210 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.90 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
5.830 |
EBITDA (p.s.) |
0.000 |
P/E |
-11.90 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.06 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.22 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.16 |
P/CF |
-19.01 |
|
|
|
|
|
|
